Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 3504073)

Published in Allergy on April 28, 2012

Authors

B Samoliński1, A Fronczak, P Kuna, C A Akdis, J M Anto, A Z Bialoszewski, P G Burney, A Bush, A Czupryniak, R Dahl, B Flood, G Galea, M Jutel, M L Kowalski, S Palkonen, N Papadopoulos, F Raciborski, D Sienkiewicz, A Tomaszewska, E Von Mutius, D Willman, A Włodarczyk, O Yusuf, T Zuberbier, J Bousquet, Council on the European Union

Author Affiliations

1: Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Poland. boleslaw.samolinski@wum.edu.pl

Articles cited by this

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet (2006) 12.04

The European Community Respiratory Health Survey. Eur Respir J (1994) 7.87

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80

Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (2007) 2.77

Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet (2008) 2.70

The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J (2001) 2.35

Early life origins of chronic obstructive pulmonary disease. Thorax (2009) 2.20

Finnish Allergy Programme 2008-2018--time to act and change the course. Allergy (2008) 2.02

Gene-environment interactions in asthma. J Allergy Clin Immunol (2009) 1.67

Immunological mechanisms of allergen-specific immunotherapy. Allergy (2011) 1.57

MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22

GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22

Reduction of asthma burden is possible through National Asthma Plans. Allergy (2010) 1.21

Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study. Otolaryngol Pol (2009) 1.13

Respiratory effects of tobacco smoking on infants and young children. Paediatr Respir Rev (2008) 1.02

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95

Poverty and chronic illness in early childhood: a comparison between the United kingdom and Quebec. Pediatrics (2010) 0.91

Sublingual immunotherapy for treating allergic conjunctivitis. Cochrane Database Syst Rev (2011) 0.91

Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol (2011) 0.90

European Union meets the challenge of the growing importance of allergy and asthma in Europe. Allergy (2004) 0.83

General practitioners' central role in management of asthma and allergic rhinitis. Allergy (2008) 0.80

Childhood influences on later lung health. Chron Respir Dis (2008) 0.78

Articles by these authors

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93

A public database for gene expression in human cancers. Cancer Res (1999) 8.81

Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess (1999) 8.63

Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol (1997) 8.51

Asthma mortality in England and Wales: evidence for a further increase, 1974-84. Lancet (1986) 7.63

The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65

Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61

Frequent paracetamol use and asthma in adults. Thorax (2000) 6.58

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07

Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87

Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A (2007) 4.27

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67

Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect Immun (1991) 3.62

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol (1994) 3.45

Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J (2008) 3.36

Hospital case notes and medical audit: evaluation of non-response. BMJ (1991) 3.31

Conversion of diploidy to haploidy. Nature (2000) 3.28

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Role of nonallergic hypersensitivity reactions in children with chronic urticaria. Allergy (1998) 3.20

The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther (2012) 3.15

Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07

Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06

Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J (2009) 3.05

Deletion of p16 and p15 genes in brain tumors. Cancer Res (1994) 3.03

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. Am J Respir Crit Care Med (2000) 2.92

The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med (2001) 2.87

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet (2002) 2.85

Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ (1991) 2.71

Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy (2000) 2.70

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet (1998) 2.66

Prediction of hypoxaemia at high altitude in children with cystic fibrosis. BMJ (1994) 2.64

Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62

CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol (1994) 2.54

An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax (2004) 2.54

Lung function in white children aged 4 to 19 years: I--Spirometry. Thorax (1993) 2.52

Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51

Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ (1999) 2.48

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

Assessment of scales of disability and handicap for stroke patients. Stroke (1991) 2.36

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol (1997) 2.32

Prevalence of scoliosis in cystic fibrosis. Pediatr Pulmonol (2012) 2.24

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22

Evidence for different subgroups of difficult asthma in children. Thorax (2001) 2.22

Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr (2002) 2.20

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2000) 2.19

APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy (2004) 2.13

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13

Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05

Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J (2010) 2.01

Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature (2001) 2.01

Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01

Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation (1997) 1.99

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99

Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J (2005) 1.98

Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories. PCR Methods Appl (1993) 1.97

Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy (2008) 1.97

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. Respir Med (2010) 1.92

Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax (1999) 1.91

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91

Flexible endoscopy of paediatric airways. Eur Respir J (2003) 1.90

Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87

Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax (2004) 1.86

Accuracy of recording of deaths from asthma in the UK: the false negative rate. Thorax (1996) 1.86

Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85

T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest (2000) 1.85